Respiratory Panel 2.1 (RP2.1) Controls (12 x 0.3mL)

ZeptoMetrix external controls have demonstrated performance on a variety of molecular assays. The product has been tested with the BioFire® FilmArray® system and provides the expected results, however performance characteristics must be established by the end user.

NATtrol Respiratory Panel 2.1 Control 1 includes Adenovirus Type 1, Adenovirus Type 3, Adenovirus Type 31, C. pneumoniae strain CWL-029, Influenza A 2009 H1N1pdm strain A/NY/02/2009, Influenza A H3N2 strain A/Brisbane/10/07, Metapneumovirus 8 strain Peru6-2003, M. pneumoniae strain M129, Parainfluenza Type 1, Parainfluenza Type 4, Rhinovirus 1A, and SARS-CoV-2 strain USA-WA1/2020.

NATtrol Respiratory Panel 2.1 Control 2 includes B. parapertussis strain A747, B. pertussis strain A639, Coronavirus 229E, Coronavirus HKU-1 Recombinant, Coronavirus NL63, Coronavirus OC43, Influenza AH1 strain A/New Caledonia/20/99, Influenza B strain B/Florida/02/06, Parainfluenza Type 2, Parainfluenza Type 3, and Respiratory Syncytial Virus (RSV) A.

• Formulated with purified, intact organisms
• Organisms are chemically modified to render them noninfectious
• Refrigerator stable—store between 2 and 8°C
• Purified protein matrix treated with 0.09% sodium azide
• 6 x 0.3 mL vials of RP2.1 Control 1 and 6 x 0.3 mL vials of RP2.1 Control 2

NATtrol products are ready-to-use, inactivated full process controls designed to evaluate performance of molecular tests. They can be used for verification of assays, training of laboratory personnel and to monitor assay-kit lot performance. NATtrol products contain intact organisms and should be run in a manner similar to clinical specimens.

• ENGLISH (PI)
• ENGLISH (SDS)

For Research Use Only. Not for use in diagnostic procedures. Quality control materials should be used in accordance with local, state, federal, and accreditation requirements. This product is not intended to replace the manufacturer's controls provided with the assay. Propagation or commercialization are prohibited without prior written consent from Antylia Scientific.

When used as a control for nucleic acid tests, the same protocols as those used to amplify extracted clinical specimens should be employed.

The suitability and performance characteristics should be determined by your laboratory for each intended usage.